期刊
CURRENT VASCULAR PHARMACOLOGY
卷 14, 期 2, 页码 130-145出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1570161114666151202204948
关键词
Purinoceptors; nitric oxide; ATP; angiogenesis; atherosclerosis; hypertension; ischaemia; migraine
Purinergic signalling is involved in the control of vascular tone and remodelling. Endothelial cells release purines and pyrimidines in response to changes in blood flow (evoking shear stress) and hypoxia. They then act on P2Y, P2X and P1 receptors on endothelial cells leading to release of EDRF mediated by nitric oxide and prostaglandins and EDHF, resulting in vasodilatation. The therapeutic potential of purinergic compounds for the treatment of vascular diseases, including hypertension, ischaemia, atherosclerosis, migraine and coronary artery and diabetic vascular disease as well as vasospasm is discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据